INM (InMed Pharmaceuticals Inc. Common Shares) Stock Analysis - Insider Trades
InMed Pharmaceuticals Inc. Common Shares (INM) is a publicly traded Healthcare sector company. As of May 19, 2026, INM trades at $1.42 with a market cap of $2.12M and a P/E ratio of -0.08. INM moved +125.50% today. Year to date, INM is -39.22%; over the trailing twelve months it is -76.93%. Its 52-week range spans $0.58 to $8.27. Rallies surfaces INM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading INM stock inside the company?
Recent INM insider activity includes MANCINI ALEXANDRA DIANE JANET sold 240, HULL ANDREW bought 37.50K, and ADAMS ERIC A bought 41.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
INM Key Metrics
Key financial metrics for INM
Metric
Value
Price
$1.42
Market Cap
$2.12M
P/E Ratio
-0.08
EPS
$-8.36
Dividend Yield
0.00%
52-Week High
$8.27
52-Week Low
$0.58
Volume
70.34M
Avg Volume
0
Revenue (TTM)
$4.94M
Net Income
$-8.16M
Gross Margin
34.53%
Recent INM Insider Trades
MANCINI ALEXANDRA DIANE JANET sold 240 (~$42.312) on Jul 31, 2024.
HULL ANDREW bought 37.50K (~$14.63K) on Feb 21, 2024.
ADAMS ERIC A bought 41.60K (~$14.92K) on Feb 20, 2024.
INM analyst coverage data. Average price target: $0.00.
Common questions about INM
Who is trading INM stock inside the company?
Recent INM insider activity includes MANCINI ALEXANDRA DIANE JANET sold 240, HULL ANDREW bought 37.50K, and ADAMS ERIC A bought 41.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for INM?
Yes. Rallies tracks INM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is INM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INM. It does not provide personalized investment advice.